BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9418826)

  • 1. Potent topical steroid in a Chinese herbal cream.
    Wood B; Wishart J
    N Z Med J; 1997 Nov; 110(1055):420-1. PubMed ID: 9418826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Cap and corticosteroids.
    Boyce D
    Dermatol Online J; 1997 Dec; 3(2):11e-11f. PubMed ID: 10328674
    [No Abstract]   [Full Text] [Related]  

  • 3. Immediacy is both a liability and an asset of the Internet.
    Huntley A
    Dermatol Online J; 1997 Dec; 3(2):11b. PubMed ID: 10217739
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin Cap: what have we learned, and when did we learn it?
    Smith K
    Dermatol Online J; 1997 Dec; 3(2):11c. PubMed ID: 10217740
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical availability of clobetasol-17-propionate from cream and ointment.
    Dyderski S; Grześkowiak E; Szałek E; Mrzygłód A
    Acta Pol Pharm; 2001; 58(6):435-8. PubMed ID: 12197615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatographic determination of clobetasone-17-butyrate in ointments.
    Patel AG; Patel RB; Patel MR
    J Assoc Off Anal Chem; 1990; 73(6):893-5. PubMed ID: 2289922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
    Lee CS; Koo J
    J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical steroids and UV radiation in psoriasis.
    Petrozzi JW
    Arch Dermatol; 1983 Mar; 119(3):207-10. PubMed ID: 6824358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class I topical corticosteroid use by psoriasis patients in an academic practice.
    Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
    Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P
    J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical corticosteroids.
    Katz HI
    Dermatol Clin; 1995 Oct; 13(4):805-15. PubMed ID: 8785885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations.
    Carbone M; Arduino PG; Carrozzo M; Caiazzo G; Broccoletti R; Conrotto D; Bezzo C; Gandolfo S
    J Oral Pathol Med; 2009 Feb; 38(2):227-33. PubMed ID: 19141065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile pustular psoriasis associated with steroid withdrawal syndrome due to topical corticosteroid.
    Saeki H; Watanabe A; Tada Y; Kakinuma T; Komine M; Ihn H; Asahina A; Etoh T; Kitanaka S; Sato U; Kano H; Igarashi T; Tamaki K
    J Dermatol; 2008 Sep; 35(9):601-3. PubMed ID: 18837708
    [No Abstract]   [Full Text] [Related]  

  • 18. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
    Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
    J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.